The England and Wales High Court’s ruling in Accord v Novartis may not rewrite the law on plausibility, but it does signal a pragmatic approach that could provide greater certainty for life sciences innovators
Cassie Hill, partner at Mishcon de Reya, discusses rebuilding client relationships after maternity leave and the pressures facing women at a pivotal stage of their career
PE-backed practices now comprise the majority of ranked firms for patent prosecution in the Netherlands, but competitors are confident about their decision to remain independent
By accepting a relatively small sample of infringing content to grant worldwide relief, a UK court has adopted a pragmatic approach that could reduce the time and expense involved in huge enforcement actions
Attorney Oran Friar and trainee attorney Harry Cunliffe at Reddie & Grose, share that patent filings for clinical LLMs are surging, but success in the UK and Europe hinges on demonstrating technical innovation
Maria Kilimiris of Patrinos & Kilimiris says the decision on the ‘Belvedere Mykonos Club’ mark highlights the importance of complementary goods and services as a factor in opposition cases
Andrea Delbarba and Claudia Finetti of Bugnion SpA explain how supplementary protection certificates extend pharmaceutical patent protection, the role of paediatric extensions, and recent Italian clarifications on fees and regulatory processes
Senior Maiwald lawyers outline the strategy behind the firm’s recognition as EPO Proceedings Firm of the Year at the Managing IP EMEA Awards 2025 and discuss key developments in the European intellectual property space
